Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Langen
Clinical trial register · Germany

Clinical Trials in Langen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Langen

14 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Essen, Dessau, Hamburg, Hanover, Heidelberg, Koblenz, Langen, München
2026-05-21
Recruiting
Bristol-Myers Squibb
Phase 3
750
Wangen, Landshut, Rosenheim, Kaiserslautern, Langen, Wiesbaden, Cologne, Dortmund
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Esslingen am Neckar, Augsburg, München, Frankfurt am Main, Langen, Hanover, Düsseldorf, Essen
2025-09-11
Active, closed
Celgene
Phase 3
850
Ulm, Augsburg, Bayreuth, Erlangen, Langen, Hanover, Koblenz, Halle
2024-06-19
Recruiting
BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation
NCT05717192Emphysema or Chronic Obstructive Pulmonary Disease
IHF GmbH - Institut für Herzinfarktforschung
Not applicable
224
Berlin, Bonn, Essen, Halle, Heidelberg, Hemer, Immenhausen, Langen
2024-04-24
Recruiting
Novartis Pharmaceuticals
Phase 3
1,444
Freiburg im Breisgau, Munich, Regensburg, Weiden in Der Oberpfalz, Langen, Hildesheim, Bergisch Gladbach, Bielefeld
2024-02-28
Recruiting
Rijnstate Hospital
Not applicable
300
Langen, Frankfurt, Leipzig
2023-05-26
Active, closed
Hoffmann-La Roche
Phase 3
922
Bad Nauheim, Bamberg, Essen, Freiburg im Breisgau, Heidelberg, Hildesheim, Homburg/Saar, Langen
2022-07-18
Active, closed
AstraZeneca
Phase 3
644
Aschaffenburg, Bonn, Frankfurt am Main, Georgsmarienhütte, Hanover, Heilbronn, Koblenz Am Rhein, Langen
2022-05-16
Recruiting
University of Sydney
Phase 4
50,000
Albstadt, Berlin, Bochum, Darmstadt, Elsenfeld, Hechingen, Homburg, Langen
2016-06
Active, closed
Smith & Nephew, Inc.
Observational
163
Langen, Hamburg, Saarbrücken-Dudweiler, Straubing
2015-09
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/langen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Langen.

How many clinical trials are recruiting in Langen?

8 of the 14 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Langen), 14 studies
PhaseStudiesRecruitingShare
Phase 37350%
Not applicable2214.3%
Phase 2/32214.3%
Observational107.1%
Phase 2107.1%
Phase 4117.1%

Most active sponsors

Lead sponsors with the most studies (Langen)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche42
AstraZeneca20
Bristol-Myers Squibb22
Celgene10
IHF GmbH - Institut für Herzinfarktforschung11
Novartis Pharmaceuticals11
Rijnstate Hospital11
Smith & Nephew, Inc.10
University of Sydney11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.